Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 30/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and HRZ (H-Isoniazid, R-Rifampin, Z-Pyrazinamide) treatment group.

Abundance in Group 1: increased abundance in HRZ(H-Isoniazid, R-Rifampin, Z-Pyrazinamide)

NCBI	Quality Control	Links
Anaerotruncus
Christensenella
Pseudobacteroides
Roseburia
Anaerosporobacter
Butyricicoccus
Ethanoligenens
Eisenbergiella
Erysipelotrichaceae
Enterorhabdus
Arthrobacter
Anaerostipes
Pseudoflavonifractor
Intestinimonas
unclassified Pediococcus
Blautia
Flavonifractor
Acetatifactor
Thomasclavelia
Mucispirillum
Eubacterium
Asaccharobacter
Oscillibacter
Anaeroplasma
Barnesiella
Dysgonomonas
Anaerovorax
Erysipelothrix
Alistipes
Bacteroides
Akkermansia
Lachnospiraceae
Tannerella

Revision editor(s): KateRasheed